Atlas Trials

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

Clinical trial NCT01492582 · COMPLETED

Trial details

NCT number
NCT01492582
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer SurvivorPrevention of Human Papillomavirus Infection
Start date
2012-07-01
Primary completion
2019-02-08
Enrollment
1499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.